此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

中风后瘫痪手臂的经耳迷走神经刺激 (taVNS) 和机器人训练 (VaNSaRTS)

2026年10月2日 更新者:Bruce Volpe、Northwell Health

评估使用经耳迷走神经刺激 (taVNS) 和机器人训练来改善中风后上肢运动恢复

To determine whether treatment with transauricular vagus nerve stimulation (taVNS) during the training of an affected upper limb of a patient with chronic stroke on a robotic motor task alters the motor impairment.

研究概览

地位

完全的

条件

详细说明

The investigators will evaluate whether transauricular vagus nerve stimulation (taVNS) delivered during extensor movements executed on a robotic device will alter the clinical measurement of upper limb motor performance in 45 patients with chronic stroke.

Patients will engage the robot first with their unaffected limb. This practice will ensure understanding and serve to activate the hemisphere ipsilateral to the impaired limb. Patients are likely to perform this activity quickly, there will not be any taVNS during this part of the procedure. Patients will then wear the taVNS device on the left ear for the duration of the subsequent phase of the robotic training. During this phase the patient will engage the robotic device with the affected limb and complete the protocol and the stimulation or sham stimulation will occur with every extensor movement.

研究类型

介入性

注册 (实际的)

40

阶段

  • 阶段2

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • New York
      • Manhasset、New York、美国、11030
        • Feinstein Institutes at Northwell Health

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 85年 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • In receipt of full vaccination status and no recent upper respiratory symptoms and no loss of taste or olfaction.
  • Individuals between 18 and 85 years of age
  • First single focal unilateral supratentorial ischemic stroke with diagnosis verified by brain imaging (MRI or CT scans) that occurred at least 6 months prior
  • Cognitive function sufficient to understand the experiments and follow instructions (per interview with Speech Pathologist or PI)
  • Fugl-Meyer assessment 12 to 44 out of 66 (neither hemiplegic nor fully recovered motor function in the muscles of the shoulder, elbow, and wrist).

Exclusion Criteria:

  • Recent fever or upper respiratory symptoms.
  • Botox treatment within 3 months of enrollment
  • Fixed contraction deformity in the affected limb
  • Complete and total flaccid paralysis of all shoulder and elbow motor performance
  • Prior injury to the vagus nerve
  • Severe dysphagia
  • Introduction of any new rehabilitation interventions during study
  • Individuals with scar tissue, broken skin, or irremovable metal piercings that may interfere with the stimulation or the stimulation device
  • Highly conductive metal in any part of the body, including metal injury to the eye; this will be reviewed on a case by case basis for PI to make a determination
  • Pregnant or plan on becoming pregnant or breastfeeding during the study period
  • Significant arrhythmias, including but not limited to, atrial fibrillation, atrial flutter, sick sinus syndrome, and A-V blocks (enrollment to be determined by PI review)
  • Presence of an electrically, magnetically or mechanically activated implant (including cardiac pacemaker), an intracerebral vascular clip, or any other electrically sensitive support system; Loop recorders will be reviewed on a case by case basis by PI and the treating Cardiologist to make a determination

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
假比较器:Affected Limb

Patients will wear the taVNS device on the left ear for the duration of the subsequent phase of the robotic training. During this phase the patient will engage the robotic device with the affected limb and complete the protocol and the stimulation or sham stimulation will occur with every extensor movement.

Within subject. Sham controlled. Double blind, the patient will not know whether they are receiving taVNS, all patients feel a ramp up current but only the active group will receive timed stimulation bursts during the robotic protocol that engages the affected limb. '

Patients will wear the taVNS device on the left ear for the duration of the subsequent phase of the robotic training. During this phase the patient will engage the robotic device with the affected limb and complete the protocol and the stimulation or sham stimulation will occur with every extensor movement.

无干预:Unaffected limb

Patients will engage the robot first with their unaffected limb. This practice will ensure understanding and serve to activate the hemisphere ipsilateral to the impaired limb. Patients are likely to perform this activity quickly, there will not be any taVNS during this part of the procedure.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Fugl-Meyer Motor Scale for the upper extremity
大体时间:30-45minutes

A standard well characterized measure of the movement ability of the subjects arm- shoulder, elbow, wrist, hand and fingers.

30-45minutes

次要结果测量

结果测量
措施说明
大体时间
Action Research Arm Test (ARAT)
大体时间:30-45minutes

A standard evaluation of 19 different real world actions of the arm, including movements around the shoulder, elbow, wrist, hand and fingers.

30-45minutes

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Bruce T Volpe, MD、Feinstein Center for Molecular Medicine
  • 研究主任:Timir Datta Chaudhuri, PhD、Feinstein Center for Bioelectronic Medicine

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2022年9月12日

初级完成 (实际的)

2026年4月13日

研究完成 (实际的)

2026年4月13日

研究注册日期

首次提交

2022年3月29日

首先提交符合 QC 标准的

2022年4月13日

首次发布 (实际的)

2022年4月21日

研究记录更新

最后更新发布 (实际的)

2026年10月6日

上次提交的符合 QC 标准的更新

2026年10月2日

最后验证

2025年5月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅